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Abstract 
This paper focuses on the analytic modelling of responses of cells in the body to 
ionizing radiation. The related mechanisms are consecutively taken into account and 
discussed. A model of the dose- and time-dependent adaptive response is considered, 
for two exposure categories: acute and protracted. In case of the latter exposure, we 
demonstrate that the response plateaus are expected under the modelling 
assumptions made. The expected total number of cancer cells as a function of time 
turns out to be perfectly described by the Gompertz function. The transition from a 
collection of cancer cells into a tumour is discussed at length. Special emphasis is put 
on the fact that characterizing the growth of a tumour (i.e., the increasing mass and 
volume) the use of differential equations cannot properly capture the key dynamics – 
formation of the tumour must exhibit properties of the phase transition, including self-
organization and even self-organized criticality. As an example, a manageable 
percolation-type phase transition approach is used to address this problem. 
Nevertheless, general theory of tumour emergence is difficult to work out 
mathematically because experimental observations are limited to the relatively large 
tumours. Hence, determination of the conditions around the critical point is uncertain. 
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1. Introduction 
The development of cancer in the body by transition of normal cells to cancerous ones 
is a complicated multistep process in which many non-linear processes play a 
significant role. A living cell is a very complex biophysical system. Radiation-induced 
adaptive response, the bystander effect, and abscopal effects at low radiation doses 
and dose rates are the key processes which need to be addressed when modelling 
radiation carcinogenesis. 
According to the classical theory, cancer is initiated by a set of mutations in certain 
genes in a cell. The mutations arise because of inefficient DNA lesion recognition 
and/or repair. Unrepaired lesions that result from the DNA replication errors and the 
activity of metabolic free radicals can produce spontaneous mutations occurring at the 
rate from about 1·10-7 to 5·10-6/gene/cell/year (Steen, 2000). This relatively broad 
range, which is important for further considerations, may be due to variable output 
and/or activity of repair proteins. Their activity, in turn, can be modified by exogenous 
stimuli. 
Exogenic lesions, caused, e.g., by exposure to intermediate and high doses of ionizing 
radiation, may lead to the development of cancer through radiation-induced genetic 
and epigenetic changes. Within this framework, biological effects of ionizing radiation 
are modelled by a step-by-step introduction of key processes that lead from single 
changes in the DNA to a full-blown cancer. In contrast to exposures at intermediate 
and high radiation doses, absorption of low radiation doses, especially when delivered 
at low dose rates is unlikely to produce multiple irreparable DNA lesions, but still alerts 
the DNA damage surveillance system. This results in a stimulated repair of numerous 
DNA lesions in genes, including those associated with cell replication and metabolism. 
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In this case, the increased repair capacity of the cells (and therefore of the whole 
organism in the case of whole body exposure), which is manifested by a decreased 
overall rate of fixed mutations in the DNA, can translate into reduced risk of neoplastic 
transformation of cells and of cancer development. The degree of natural protection 
stimulated by low radiation doses depends on the type of radiation, its dose, and dose 
rate.  
Within a standard adaptive response study design, a small priming dose is used to up-
regulate adaptive-response mechanisms (which represent a mild stress response and 
in vivo can involve a hierarchy of natural protective mechanisms (Scott, 2014, 2017). 
A large challenging dose is then administered (usually shortly after the priming dose) 
and biological endpoints (e.g., the rates of cell deaths, mutation or neoplastic 
transformation) of such a combined exposure are compared with the ones when only 
the challenging dose is used. A reduced frequency of adverse biological effects in the 
presence of the priming dose indicates a rapid adaptive response (i.e., rapid 
adaptation) induced between the two exposures; which may involve epigenetic 
changes (Scott et al., 2009). The priming dose can be brief or protracted for these 
effects to take place. In addition, the priming dose can lead in vivo to reduction in the 
rates of mutations (Ogura et al., 2009) and neoplastic transformation (Redpath et al., 
2001), to a level below the spontaneous frequency; presumably as a result of up-
regulation of the body’s natural defenses (Scott 2014, 2017). 
An important role in cancer formation may be played by close-by and distant cells in 
tissue through intercellular signalling. These signals are responsible for induction of 
bystander (nearby cells) and abscopal (distant cells) effects. However, detailed 
mechanisms of these effects have not yet been fully resolved and there are 
inconsistencies in their understanding. For example, some authors reported that in 
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studies of the bystander effect, signals from irradiated cells to a unirradiated cells 
surrounding an irradiated one exacerbate lesions in the latter (Marin et al., 2015; Marcu 
et al., 2009). However, other studies demonstrate elimination of such lesions (e.g. 
Mothersill and Seymour 2005) through the induction of apoptosis (e.g. self-destruction 
of both hit and not hit transformed cells). The latter is now considered a different form 
of adaptive response and relates to stimulated up-regulation of natural protective 
mechanisms (Scott 2014). In the case of the bystander effect one can try to model it 
(e.g. Khvostunov and Nikjoo 2002; Hattori et al. 2015) and use Monte Carlo simulations 
(e.g., as in the paper by Fornalski et al. (2017), Hattori et al. (2015)), and the result will 
clearly depend on the employed model. It is believed that mechanisms of bystander 
effects and adaptive response (commonly associated with low dose exposures) are 
basic components of the cellular homeostatic response (Marcu et al., 2009). Adaptive 
response to radiation has been described theoretically and modelled in a number of 
ways. However, none of the currently available quantitative risk models have covered 
the path from the deposition of radiation energy in a cell to a developed (i.e. 
neoplastically transformed) cancer cell. As will be discussed in section 6, in order to 
fully describe this process, it is evident that any change from a simple collection (set) 
of cancerous cells to a more complex system of a malignant tumour must be 
associated with a basic reorganization of the initial set into a new entity, the properties 
of which cannot be readily and uniquely derived from the properties of the initial 
system. Until a more precise understanding of the underlying mechanisms is reached, 
we will focus only on description of hit cells. Thus, one has to accept the fact that the 
calculations presented in this paper will have to be corrected for the two 
aforementioned effects once their mathematical form and relative strengths are worked 
out. 
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Describing (or modelling) the development of radiogenic cancer from the initial 
radiation-induced/exacerbated genetic and/or radiation-exacerbated genetic and/or 
epigenetic changes to a clinically detectable neoplasm may be regarded as an 
unattainable task. Moreover, since there are different ways for cancer to arise, different 
conceptual models have to be introduced. One of these models was introduced by 
Hanahan and Weinberg in their two seminal papers (2000; 2011). Their conceptual 
model focused on the hallmarks of cancer which provide guidance on the key 
processes that should be addressed when developing a quantitative, mechanism-
based model of the development (risk) of cancer.  
We propose a possible biophysical interpretation of the processes of creation of 
radiation-induced changes in the DNA and the ensuing mutations in exposed cells. 
Transformation of a mutated cell into a neoplastic one is also discussed. In all these 
processes, the adaptive response mechanism (which has been proposed and 
successfully used in earlier theoretical studies) is implemented and discussed. Most of 
the mathematical formulae will be presented as proper probability functions which can 
be used in Monte Carlo simulations. 
The paper is organized as follows: in section 2, we address the possible outcomes of 
exposing a cell to ionizing radiation. In section 3 the path from lesions to mutations is 
described, mainly basing on the Random Coincidence Model - Radiation Adapted 
(RCM-RA) (Fleck et al. 1999). Section 4 describes adaptive responses of cells 
exposed to acute or protracted (continuous) irradiation. This leads to considerations of 
transformation of a mutated cell into a cancer cell, including the relationships between 
the dose-rate and the number of mutations on the number of the developed cancer 
cells (Section 5). A more detailed description of the inception of a tumour from pre-
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cancerous cells is the subject of Section 6. Conclusions are presented in the final 
section of the paper. 
The general idea of this modelling utilized by us is presented on the flow-chart below, 
Fig.1. Every step is described in each section of the paper. 
 
 
 
Fig.1. Flow-chart of the model used. The meanings of symbols are explained in the 
Table 1 and in the text of the paper. 
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Table.1. Summary of main probability functions in the presented model.  
Probability function Described process or explanation 
Phit radiation DNA hit in a cell  
PL Creation of the DNA damage from the hit 
S1 initiation of single base change or a SSB per unit of time 
St any of all considered types of DNA breaks occurring in time 
Pm mutation creation per unit of time   
PR repair process, reduction of number of lesions per unit of 
time  
PAR radiation-activated mechanism of the adaptive response 
PNR natural repair of DNA lesions  
Pc(m) cell transformation into a cancer cell due to number of 
accumulated mutations in time  
 
 
2. Creation of lesions in a cell after deposition of radiation energy  
The interaction of ionizing radiation with matter depends on the type R of radiation, and 
on its energy, E. This interaction is typically described by the cross section for a given 
process, (R,E). The cross section of interaction of ionizing radiation with matter (or a 
cell) depends on many physical effects. As an example, an interaction of a single 
photon with matter is briefly described in Appendix A.  
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Ionization events in the cell may lead to several biophysical effects. Here, only lesions 
that may lead to neoplastic transformation will be considered, such as radiation-
induced single (SSBs) and double strand (DSBs) breaks will be considered. 
As an example, for electrons of energies 5.6 eV and 9.6 eV, the values of SSB cross-
sections are 2.4·10-14 cm2 and 4.7·10-14 cm2, and those of the DSB cross-sections are 
4.1·10-15 cm2 and 4.5·10-15 cm2, i.e. the former are by an order of magnitude smaller 
than the latter (Chen et al. 2016).  
In addition to the cross sections, one needs also to consider the probability of a 
radiation hit at the DNA, Phit, which depends on the flux of impinging particles, and the 
surface density (number per cm2) of the elementary objects (e.g. the DNA or its 
secondary structures) to be hit. The probability of a hit can be combined with the dose 
D (i.e., dose rate, ?̇?, multiplied by time of exposure) absorbed by the object. Such a 
dependence may be linear at a low dose; however one could postulate that it must 
saturate at a high dose. Thus, the total probability function describing the creation of a 
DNA damage (lesion) after the radiation hit, PL, can be described as: 
𝑃𝐿 = 𝐴𝜎𝑃ℎ𝑖𝑡 = 𝐴𝜎 (1 − 𝑒
−𝑐𝐷) ,    (2.1)  
where A is a normalization constant, and c denotes a scaling constant. Because cross 
sections are expressed in barns b (1b = 10-24 cm2), constant A must be expressed in 
cm-2. Obviously, it is the product of the thickness of the target (in cm) and the numerical 
density of the interacting objects, (e.g. number of cells per cm3). The concept of Phit in 
eq. (2.1) was originally used by us in the Monte Carlo chain cellular model (Fornalski 
et al. 2011), but the validity of this formula has not been verified. Now, such a validation 
is presented in Appendix B. 
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3. Phenomenological descriptions of lesions and mutations in irradiated cells 
When a damage to the DNA is identified as a single lesion with probability PL, one can 
consider the probability of creating a mutation resulting from an unrepaired or 
improperly repaired lesions. The process of mutation creation may be described by a 
polynomial, presumably dependent on the linear energy transfer (LET) of a given type 
of radiation R (Kellerer and Rossi 1976). In particular, one can assume that the 
probability of a mutation caused by a mixed radiation field may have the form: 
𝑝1 = 1 − 𝑒
− ∑ ∑ 𝑎𝑖,𝑅𝐷𝑅
𝑖
𝑖=0𝑅 ,    (3.1) 
where DR represents an absorbed dose of radiation R, and ai,R are experimentally 
derived parameters for a given type of radiation R. Obviously the units of ai,R  must 
ensure the dimensionless product in the exponential function. At low doses eq. (3.1) 
can be approximated by: 
𝑝1 = ∑ ∑ 𝑎𝑖,𝑅𝐷𝑅
𝑖
𝑖=0𝑅  .    (3.2) 
Form (3.2) is used by International Atomic Energy Agency in biodosimetric standards 
(IAEA 2011) where aberrations (such as dicentrics) are used to assess the dose 
received by the irradiated person. According to conclusions by Kellerer and Rossi 
(1976) and Szłuińska et al. (2005), this probability (p1) is linear for high LET radiation, 
such as neutrons (i = 1), and linear-quadratic (i = 1, 2) for low LET radiation, such as 
gamma- or X-rays.  
A different approach was proposed by Fleck et al. (1999) who presented a biophysical 
model initially considering the probabilities of SSBs and DSBs induced in the DNA 
either one after another (SSBs) or during a massive attack of reactive oxygen species 
(ROS) or ionizing radiation (DSBs). In their RCM-RA model, the dose-rate serves as a 
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crucial parameter in the role of ionizing radiation in this process. Assuming that the 
metabolic chemical burden production rate is C (per unit time) and the dose rate is ?̇?, 
the probability of a single base change or a SSB per unit of time is (original 
abbreviations): 
𝑆1 =  𝛼𝐶 + 𝛽?̇?,     (3.3) 
where  and  are weighting factors. The first term on the right side of eq. (3.3) 
describes the probability of damage (per unit time and a nucleotide) arising from the 
natural metabolism. The second term describes a similar effect, caused by ionizing 
radiation. The  constant (in Sv-1 times the time unit) has been also calculated (for low 
LET radiation only) by Fleck et al., 1999; see their eq. (A.10). The  coefficient is 
dimensionless. 
Let the average time needed for error-free repair be It may be expected that this 
must depend on the efficiency of repair enzymes. The average number of repaired 
lesions within   is: 
𝑆2 = (𝛼𝐶 + 𝛽?̇?)𝜏.     (3.4) 
Consequently, the probability per unit time of the development of a DSB as a result of 
the sequential production of two SSBs closely related in space and time, should be 
proportional to: 
𝑆𝑡 =  (𝛼𝐶 + 𝛽?̇?)
2
𝜏.     (3.5) 
In this model (Fleck et al., 1999) the rate of the poorly repairable DSBs is linear in the 
time needed to repair single lesions. Even if this assumption may not necessarily hold 
true, it may be accepted as a first approximation. The kinetics of a DSB repair in 
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humans was recently considered in greater detail by Jain et al. (2017) who 
demonstrated that irradiation at low dose rates increases the efficiency of such a  
repair. This finding is important in view of the level of complexity of such repair of the 
naturally created DSBs. This involves a synchronized action of dozens of proteins 
involved in the two repair pathways, homological and non-homological, occurring with 
different accumulation speeds. In the meta-analysis carried out by Kochan et al. 
(2017), the kinetics of the DSB proteins behaves with time t as 1 − exp (−𝑡/𝜏1), where 
the characteristic time 𝜏1 is the inverse accumulation speed, which could be modified 
by adaptive mechanisms. 
Assuming that the production of the repair enzymes increases up to the saturation at 
a certain equilibrium, Fleck at al. (1999) argue that it is reasonable to assume that the 
average repair time must decrease in a manner inversely proportional to (1 + 𝛿𝐷)̇ , 
where 𝛿 is a coefficient related to the enzyme production rate, possibly dependent on 
LET. This assumption stems from the following reasoning: the higher the radiation 
dose rate, the greater the number of the induced repair enzymes per time unit. With 
the elevated efficiency of the repair enzymes the probability of their presence in a close 
proximity to a damaged DNA fragment must increase. Hence, the average repair time 
of the damaged fragments should decrease with increasing dose rate. Eq. (3.5) will 
then take the form: 
𝑆𝑡 =  (𝛼𝐶 + 𝛽?̇?)
2 𝜏0
1+ 𝛿?̇?
,    (3.6) 
where denotes the characteristic repair time for the non-radiation-induced lesions. 
At a sufficiently large C this equation exhibits an apparent hormetic-like dip of St at 
the low dose rate exposure: 
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?̇?𝑚𝑖𝑛 =  
𝛿𝛼𝐶−2𝛽
𝛽𝛿
 .     (3.7) 
Instead of reliance on the postulated eq. (3.6), one could alternatively assume: 
𝑆𝑡 =  (𝛼𝐶 + 𝛽?̇?)
2
𝜏0𝑒
−𝛿?̇?,    (3.8) 
which, at small values of 𝛿?̇?, is not very different from (3.6). Eq. (3.8) represents a 
reverse situation: instead of observing the minimum, the function (3.8) exhibits a 
maximum at the value: 
?̇?𝑚𝑎𝑥 =  
2𝛽−𝛿𝛼𝐶
𝛽𝛿
 .     (3.9) 
This shows that the final description of St is very sensitive to assumptions, so one 
should be careful with postulating a definite formula for the dependence of repair time 
on the dose-rate. In fact, the main assumption which led Fleck et al. (1999) to propose 
such a dependence (3.6) was that production of the repair enzymes increases linearly 
with dose rate, which may not necessarily be the case. To conclude, we note that eq. 
(3.7) offers a limit on the coefficient , namely must be larger than or equal to 2C) 
if one accepts the shortening of  with the dose rate as in eq. (3.6), and less than 
2C) if one accepts eq. (3.8). Apparently, since the number of DNA lesions should 
initially increase and decrease only after maximal accumulation of the repair enzymes 
(Kochan et al, 2017) eq. (3.8) could also be accepted based on such phenomenological 
considerations. 
Let us note that at very low dose rates the St values behaves as: 
𝑆𝑡~ 𝑐𝑜𝑛𝑠𝑡 (1 − 𝛿?̇?),     (3.10) 
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where const=( 𝛼𝐶)20. Let us also note that the positive value of (?̇?)
𝑚𝑖𝑛
may equally 
well bind any of the four constants appearing in the eq. (3.7). The hormetic-like 
minimum observed in Fig.1 of Fleck et al. (1999) can be explained based on the 
assumption of reduction of repair time with the dose-rate as in eq. (3.6) without 
considering that the repair time may vary with time after irradiation. Last but not least, 
at high dose rates, St becomes either proportional to the dose rate, if eq. (3.6) is used, 
or tends to zero, if eq. (3.8) is used. In the former case, one observes a linear no-
threshold (LNT) behaviour while eq. (3.8) demonstrates the decreasing probability of 
DSBs production due to the shortening of the time of the first SSB repair. In such a 
situation, a DSB would be expected to mainly be produced by a mechanism different 
than the consecutive induction of two juxtaposed SSBs. At very low dose rates or at 
small value of  the use of either of equations, (3.6) or (3.8), practically yields the same 
results. 
Fleck et al. (1999) assumed that the repair of double lesions of all possible kinds cannot 
be successful (is error-prone) and that the rate of their appearance is proportional to 
the dose rate. With this assumption, Fleck et al. (1999) showed that the proportionality 
constant has the form (1/fnuc)𝑧𝐹̅̅ ̅𝛽
2, where fnuc denotes the average fraction of the 
volume of a cell nuclei (about 0.3), and 𝑧𝐹̅̅ ̅  is the mean specific energy per event 
deposited in a critical volume. Thus, the modified St of eq. (3.8) is: 
𝑆𝑡 =  (𝛼𝐶 + 𝛽?̇?)
2
𝜏0𝑒
−𝛿?̇? +  (1/𝑓𝑛𝑢𝑐)𝑧𝐹̅̅ ̅𝛽
2?̇? .  (3.11) 
It is easy to check that the second term on right-hand side of this equation has the 
dimension of the inverse of time, e.g., 1/s. Eq. (3.11) can still be supplemented by a 
term accounting for cell killing. Again, this model leads to LNT-type relationship at high 
dose rates and should not be used in the considered range of dose rates. In the 
15 
 
modification of the RCM-RA model (Schöllnberger et al., 2001) published two years 
later after the report of Fleck et al. (1999)  the average deposited energy 𝑧𝐹̅̅ ̅ was 
substituted by 𝑧𝐹̅̅ ̅
+ =  
𝐷
1−𝑒−𝐷/𝑧𝐹̅̅ ̅̅
, where D denotes the person’s lifetime dose (whether it 
includes natural background radiation is not clearly stated in the cited paper), and 𝑧𝐹̅̅ ̅
+ 
corresponds to the ‘mean of the specific energy deposited in the affected cell volumes, 
i.e., volumes that have experienced at least one energy deposition event’. 
Eq. (3.11) can be modified by taking SSBs into account, using the same notion as in 
eq. (3.2) (or eq. (3.1) in general). However, SSBs are usually efficiently repaired, and 
the unrepaired DSBs dominate, so, for practical reasons, there is no need to make 
such a modification.  
Using eq. (3.11) with the first term as in eq. (3.6) only, the authors of the RCM-RA 
model (Fleck et al. 1999; Schöllnberger et al.2001) obtained an almost perfect fit to the 
Cohen’s data (Cohen 1995), corrected for smoking, which means that within the scope 
of the cited papers SSBs appear to play a minor role in the creation of mutations and 
the ensuing neoplastic transformations of cells. The authors of the RCM-RA model got 
a relatively shallow minimum of the lung cancer mortality after exposures at a very low 
dose rate (roughly 1 mGy/y) and the apparently steady increase at higher dose rates. 
Such an increase has been attributed to the differential inhibition of the body’s natural 
anticancer defences (Scott et al, 2009). Within the indicated paper (which introduces 
a hormetic relative risk [HRR] model), stochastic thresholds for inhibition apply. In view 
of some other reports on the effects of radon exposures (Dobrzyński et al. 2018), this 
increase in the considered range of doses/dose rates is questionable.  
For a more complete description of the development of a mutation one needs to include 
the probability of the creation of a lesion, PL, which is represented by eq. (2.1). As 
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mentioned earlier, some additional appropriate repair mechanisms need to be 
accounted for in that modified formula as well, to allow for a reduced probability of the 
creation of a mutation. Only after considering the expected reduction in the number of 
lesions by the repair of the DNA damage sites (such as SSBs and DSBs) one can 
reliably calculate the expected number of point mutations. In addition, as discussed 
below, one mutation is not likely to produce a cancer cell. Thus, the joint probability 
function of mutation’s creation per unit of time can be presented as: 
𝑃𝑚𝑢𝑡𝑎𝑡𝑖𝑜𝑛 = 𝑃𝐿 ∙ 𝑝1· · (𝑆𝑡 − 𝑃𝑅),    (3.12) 
where p1 represents probability of stable mutation, PR is the general probability function 
(per unit of time) that describes repair mechanisms additional to the one already used 
in St (time dependent probability of creation of unrepairable DSB lesion with included 
repair mechanism of SSB). Let us recall that probabilities PL and p1 are dimensionless. 
Eq. (3.12) is consistent with (but different from) the Feinendegen’s model of dual action 
(Feinendegen et al. 2010, 2012). The probability of the occurrence of detrimental 
effects, St, can be described by eq. (3.11) or by other forms, like the one presented by 
Dobrzyński et al. (2016).  
The repair probability, PR, can be generally composed of two main components (PR = 
PNR + PAR): natural repair of the DNA lesions (cell age dependent and possibly 
genetically determined), PNR, and the radiation-activated mechanism of adaptive 
response, PAR. That these two repair mechanisms can be simply added is the 
assumption only, valid when the radiation-induced repair is not making use of the 
natural protective mechanisms. If this is not the case, PAR should be considered as 
PNR(1+RI), where RI is describing stimulation of the natural protection due to radiation. 
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PNR can likely be approximated by the inverted sigmoidal function (the Mehl-Avrami 
equation), where the repair possibilities decrease over time: 
𝑃𝑁𝑅 = 𝐶 𝑒
−𝑎 𝐾𝑛 ,    (3.13) 
where C and a are scaling constants, and K is the normalized age of the irradiated cell, 
i.e. the real time divided by an accepted characteristic time constant. The parameter n 
is of crucial importance because it is determined by down-regulation of the repair 
enzymes with the cell’s age.  
A large fraction of unrepaired cells also undergo mitotic death or apoptosis 
(programmed cell death), and thus do not contribute to the mutation load (Bauer 2007). 
In the context of oncogenesis, both types of cell death offer a ‘successful’ resolution of 
ineffective repair of the DNA damage, especially after a small number of dead cells 
can be tolerated. Moreover, it seems that removal of already transformed cells is also 
possible after irradiation at low doses through intercellular apoptotic signalling (Bauer 
2007). 
 
4. Adaptive response to ionizing radiation 
The adaptive response phenomena include triggering of repair mechanisms, especially 
in the DNA, after irradiation of cells, tissues, or a whole organisms. The number and 
efficiency of the activated repair enzymes are associated with the number of ionization 
events, which depend on the dose and dose rate. Adaptive response is assumed to be 
reasonably well accounted for using equations similar to eq. (3.1) or (3.2). The main 
implication of the latter is that the efficiency of repair is expected to grow continuously 
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with the dose of radiation. However, since the effectiveness of repair saturates at high 
doses, this equation is expected to be reliable only for low doses. 
Additionally, one can assume that the efficiency of the repair enzymes decreases 
exponentially with increasing dose. In what follows we shall use an exponential decay 
in which: 
𝑝2 = 𝑒
−𝑏𝐷 .      (4.1) 
Finally, the dose/dose-rate related probability of the effectiveness of the repair 
enzymes can be described as a product of eq. (3.2) and (4.1): 
𝑃(𝐷) = 𝑝1𝑝2 = (∑ ∑ 𝑎𝑖,𝑅𝐷𝑅
𝑖
𝑖=0𝑅 ) 𝑒
−𝑏𝐷.   (4.2) 
As already mentioned, all equations (3.1), (3.2), (4.1) and (4.2) are connected with the 
dose/dose-rate relation. 
With respect to the time dependence one can assume, as the first approach, that the 
number of repair enzymes and their effectiveness increases with time (after an 
initiating event) with a probability: 
𝑝3 = 𝜇0 + 𝜇 𝑡 ,     (4.3) 
where  describes the enzymes production rate after a pulse of radiation. This 
assumption should be not far from reality especially at short times after the irradiation. 
If one considers a single radiation pulse only, the effectiveness of the activated 
enzymes, after the initial rise in their concentration, must also decrease with time with 
a certain time constant (lifetime), 1/λ (IAEA 2011). Were the probability of such a 
decrease per unit of time constant, this decrease would be described by: 
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𝑝4 = 𝑒
−𝜆 𝑡  ,     (4.4) 
which finally would lead to the overall time dependence: 
P(t) = 𝑝3𝑝4 = (𝜇0 + 𝜇𝑡)𝑒
−𝜆𝑡  .   (4.5) 
The general shape of eq. (4.5) is similar to the shape of eq. (4.2) and can be 
generalized in an analogous manner: 
𝑃(𝑡) = (∑ 𝜇𝑛𝑡
𝑛
𝑛=0 )𝑒
−𝜆 𝑡 ,   (4.6) 
where the index n may be of non-integer type as the proportionality of p3 with time still 
remains an arbitrary assumption. For practical reasons, however, the simplified form 
given by eq. (4.5) is preferred. 
Finally, the joint probability function of the adaptive response should be dependent 
both on the dose-rate, Ḋ, and the time, t. Obviously the product of these two 
parameters is the absorbed dose. One should also note that at high doses the 
consideration of a time-dependent adaptive response makes no sense because of the 
smallness or non-existence of adaptedness (Fornalski 2014). In numerical calculations 
one introduces time steps, k ∊ {1,…, kmax} and the dose per unit time step (D), i.e. the 
dose rate rather than the dose. The value of the time step has to be chosen 
independently. It seems convenient to use the time step equal to  as introduced in 
eq. (3.4). As indicated above, both variables can be used independently in two different 
equations, depending on the context. Thus, the simplest forms of the appropriate 
functions are: 
P(D) = 𝛼1𝐷
𝑛𝑒−𝛼2𝐷 ,    (4.7) 
P(k) = 𝛼4𝑘
𝑚𝑒−𝛼3𝑘 .    (4.8) 
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Let us note that the normalization constants, 1 and 4, are dependent on the 
remaining parameters n and m (higher than 1 to obtain a hunchbacked shape of the 
curves), so that 1 = 1(n,2), and 4 = 4(m, 3). The true dependence is determined 
by the assumed ranges of D and k, respectively. This approach was successfully used 
in the Monte Carlo modelling where the joint probability function of the adaptive 
response was calculated in a discrete form (Fornalski 2014; Dobrzyński et al. 2016; 
Fornalski et al. 2017): 
𝑃𝐴𝑅 = 𝐶 ∑ 𝐷
𝑛𝐾
𝑘=0 (𝐾 − 𝑘)
𝑚𝑒−𝛼2𝐷−𝛼3(𝐾−𝑘) ,   (4.9) 
where C represents a normalization constant and K – the cell’s age given as the 
number of elementary time steps. This equation may be written in a continuous form 
(Fornalski 2014; Dobrzyński et al. 2016; Fornalski et al. 2017): 
𝑃𝐴𝑅 = 𝐶 ∫ ?̇?
𝑛 (𝑇 − 𝑡)𝑚𝑒−𝛼2?̇?−𝛼3(𝑇−𝑡) 𝑑𝑡
𝑇
𝑡=0
  .  (4.10) 
Let us note that D in eq. (4.9) denotes the dose per time step, whereas the dose rate 
in the continuous form (4.10) means the dose per unit of time. Obviously such a 
modification requires the appropriate change of interpretation of the coefficients  and 
. 
The subtle point in calculations is that one should distinguish whether the dose was 
delivered in a single step or continuously over a period of time. If the dose is delivered 
in the l’th step only, its effect at the h’th time step will be described by the simplified 
version of eq. (4.9). However, if the dose is delivered continuously from the time h0 to 
time h1, the situation at each time step becomes more complicated and for the v’th time 
step: 
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𝑃(𝐷, v;  ℎ0, ℎ1) = 𝐶 𝐷
𝑛𝑒−𝛼2𝐷 ∑ (v − ℎ)𝑚𝑒−𝛼3(v−ℎ)
ℎ1
ℎ0
  ,  (4.11) 
where summation runs over h and v ≥ h1 and the dose D should be understood as a 
constant dose/step, i.e., effectively, the dose rate. If the time step is small enough, the 
sum of the discrete values on the right-hand site of eq. (4.11) can be changed to an 
integral, as in eq. (4.10): 
𝑃(𝐷, 𝑡) = 𝐶 𝐷𝑛𝑒−𝛼2𝐷  𝐼(𝑡)  ,    (4.12) 
where D denotes a single dose pulse delivered time t ago. The appropriate formulas 
of the function I(t) are given in Appendix C.  
In experiments like those carried out by Jain et al. (2017) the time of observation after 
the irradiation was close to or not more than a few times longer.  
The above considerations are important if one wants to characterize specific situations 
in regions with the elevated background radiation. In the aforementioned paper by Jain 
et al. (2017) the level of background radiation was regarded as a priming dose relative 
to the additional challenge dose to the cells. The first dose was absorbed during 
chronic (environmental) irradiation, whereas the second dose (up to 2 Gy) was applied 
over 0.5-2 minutes, i.e., in a much shorter time than the one needed for the 
development of any adverse reactions as well as of repair mechanisms. In a typical 
experiment (Shadley and Wolff 1987; Shadley et al., 1987) demonstrating the adaptive 
response in cells both priming and challenging doses were acute, i.e., applied within a 
short period of time. 
Fig. 2 shows a typical priming-dose effect as a special example of the adaptive 
response (as modelled by us, eqs 4.7-4.8), when m=1 for two irradiation times. For 
ease of the comparison, both curves were normalized to the same maximum. Fig. 2 
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displays the case of m=2 (eqs 4.7 and 4.8) and the irradiation applied between the 2nd 
and 20th time step. One can note the qualitative behaviour of this response vs. time 
which is not much different from the assumed response in each time step. During the 
irradiation the response smoothly increases with every time step, but does not 
saturate, indicating that the assumed model may not work. If it worked with chronic 
irradiation (e.g. during environmental exposures), we should grow more resistant to it 
with age (the probability of adaptation saturates at older age). Obviously, our own 
immunological fitness deteriorates with time, so this effect must be included in such 
considerations. The problem is resolved when the calculated irradiation time increases. 
Fig. 3 shows response to the irradiation time 5 times longer than in the case shown in 
Fig. 2. The response is apparently flattening out and decreases relatively soon after 
discontinuation of the irradiation. Such a dependence shows that chronic exposures 
cause a constant adaptation of the organism to radiation which was also demonstrated 
in the earlier Monte Carlo studies (Fornalski 2014). Although the strength of the 
maximal adaptive response is limited, it can still be substantial. Therefore, as observed 
by Jain et al. (2017), inhabitants of regions with a substantially elevated background 
radiation can indeed present with a higher radio-resistance.  
If the dose-rate becomes too high for the enzymes to perform the error-free repair, the 
constant parameter related to the dose-rate (e.g. b in eq. (4.1)) should have the 
meaning of the inverse of characteristic dose-rate which describes the effectiveness of 
the enzymes. In a more restrictive reasoning one should bear in mind that the formula 
like (3.1) may be different for low and high dose-rates. We know that different groups 
of genes are involved in repair actions in these two regimes, so to stay on the safe side 
one has to limit our considerations to low dose-rates. Thus, the fundamental 
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background of the adaptive response effect is described by eqs (4.7) and (4.8), with 
the most general form of: 
𝑃(𝜉) = 𝑎 𝜉𝑛𝑒−𝜆 𝜉 ,    (4.13) 
where 𝜉 may denote the dose, dose-rate, as well as the time. Were the validity of eqs 
(3.1) and (3.2) questioned, eq. (4.13) would still look reasonable. The hunchbacked 
shape of eq. (4.13), is commonly encountered in the literature. For example, 
Feinendegen found that the probability of the induction of adaptive response should 
be given by the probability distribution function with the maximum at low doses and the 
strongest effect being apparent after some period of time (Feinendegen 2016). The 
shape of this simple function is governed by two parameters, n and , only. 
 
 
Fig.2 Normalized adaptive response (as modelled by us, eqs 4.7-4.8). Irradiation time 2-5 
steps (red), and 2-20 steps (blue) for m=1 (figure on the left) and m=2 (figure on the right). 
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Fig.3 Same as Fig.2 for longer irradiation time (1-100 time steps). 
 
The maximum value of eq. (4.18) is attained at: 
𝜉𝑚𝑎𝑥 =  
𝑛

 ,     (4.14) 
where it reads: 
𝑃𝑚𝑎𝑥 = 𝑎 (
𝑛
𝜆 𝑒
)
𝑛
 .    (4.15) 
In a special case of chronic irradiation, one can easily calculate the mean lifetime or 
the mean survival fraction of the repair enzymes (or their effectiveness): 
<  > =  
∫ 
𝑛+1𝑒−𝑑
∞
0
∫ 
𝑛𝑒−𝑑
∞
0
 .    (4.16) 
Because: 
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𝑃𝑡𝑜𝑡𝑎𝑙 = ∫ 𝑎𝜉
𝑛𝑒−𝜆 𝜉𝑑𝜉 = 𝑎
𝑛!
𝜆𝑛+1
∞
0
 ,    (4.17) 
the mean lifetime <  > becomes equal to: 
<  > =  
𝑛+1
𝜆
     (4.18) 
One can note that the chronic low-rate irradiation can be treated as an infinite series 
of small radiation pulses. Indeed, integrating the sequence of (4.13) from time zero to 
infinity after the irradiation time, one obtains: 
𝑃𝑡 = 𝛼 ∫ (𝑡 + 𝜃)𝑒
−𝜆 (𝑡+𝜃)𝑑𝜃 = 𝛼
1+𝜆𝑡
𝜆2
𝑒−𝜆𝑡
∞
0
 .   (4.19) 
This result shows that in spite of a linear increase of total dose at longer times this 
probability exponentially decreases with time with the rate of the initial reaction to dose, 
i.e.. Initially, the probability increases, although non-linearly. The same effect is 
observed when the leading coefficient in eq. (4.13) is changed to t2. Then Pt changes 
to: 
𝑃𝑡 = 𝛼 ∫ (𝑡 + 𝜃)
2𝑒−𝜆 (𝑡+𝜃)𝑑𝜃 = 𝛼
2+2𝜆𝑡+𝜆2𝑡2
𝜆3
𝑒−𝜆𝑡
∞
0
 .  (4.20) 
 
5. Neoplastic transformation of mutated cells 
While the description presented above was given in terms of dose rates, the cumulative 
dose itself can be considered as well. In fact, so far the only need for the time variable 
so far has been to address repair of individual SSBs and the adaptive response. This 
repair time is stochastic rather than deterministic and is relatively short (according to 
Fleck et al. (1999), it takes about 40 minutes), so one speak about very low doses 
when one considers low dose-rates. At such doses the epigenetic term in, e.g., eq. 
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(3.3) dominates and therefore the second term on the r.h.s. of eq. (3.10) can make a 
difference. This term strictly relates to a specific cell response to irradiation: production 
of the hard to repair DSBs. This response, however, even if happens in individual cells, 
in tissues should also strongly depend on the time elapsed since the irradiation. At a 
constant dose rate, the number of the repair-resistant DSBs should increase with time, 
as should the number of the mutated cells. In eq. (3.10) the second term reflects the 
LNT approach. Thus, one must take into account that the organism counteracts a 
defective DSBs and other lesions in tissues using repair mechanisms (natural and 
adaptive responses), as proposed in eq. (3.12). 
Neglecting cooperation between cells, Fleck et al. (1999) suggested that the time 
dependent generation of cells with the 1st mutation (the number of cells per person at 
time t which incurred 1st mutation, M1) should be governed by the equation: 
𝑑𝑀1
𝑑𝑡
=  (𝐵0𝑀0 − 𝐵1𝑀1)𝑃𝑚     (5.1) 
where Pm denotes Pmutation, see eq. (3.12). M0 in this equation denotes the number of 
non-mutated cells, while B0 is interpreted as the ‘number of critical DNA bases in critical 
codons of all tumour associated genes per cell’. According to the Human Genome 
Project1, a human genome contains about 25,000 coding genes composed of 
approximately 3 billion DNA base pairs. It seems that the genome includes 291 cancer-
associated genes and more than 1% of all genes are thought to be involved in 
carcinogenesis (Futeral et al. 2004). Hence, about 1% of all the DNA bases are likely 
to represent such a critical value of B0. 
                                                             
1 www.genome.gov 
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For cells of the same tissue one can assume that B1 (the value similar to B0, but after 
the first mutation) should not be much different from B0. It would seem that there should 
be a minor error if both of these coefficients were substituted by a single one, B = B0 = 
B1. Let us note that in the original formulation by Fleck et al. (1999) the last multiplier 
on the r.h.s of eq. (5.1) is St. In order to preserve our reasoning, this function was 
replaced by the probability of mutation, Pm, which is much closer to reality. 
The solution of differential equation (5.1) is: 
𝑀1 =  𝑀0(1 − 𝑒
−𝐵𝑃𝑚𝑡) ,   (5.2) 
which shows at small values of time a linear growth of M1 with time (as in eq. (B37) in 
(Fleck et al, 1999)) and at high t-values a saturation (equilibrium), hence 𝑀1 =  𝑀0.The 
saturation, however, most likely overestimates the number of single mutated cells as 
𝑀1 =  𝑀0 means that the number of mutated cells is equal to the number of all cells. 
To find the expected number of cells with two mutations Fleck et al. (1999) consistently 
suggests equation similar to eq. (5.2): 
𝑑𝑀2
𝑑𝑡
=  (𝑀1 − 𝑀2)𝑃𝑚  .    (5.3) 
The solution is: 
𝑀2 =  𝑀1(1 − 𝑒
−𝐵𝑃𝑚𝑡) = 𝑀0(1 − 𝑒
−𝐵𝑃𝑚𝑡)2 .  (5.4) 
With the increase of time the number of such cells must be smaller than M1. Equation 
(5.4) can next be easily generalized to the case of m mutations per cell (see eq. (5.6)). 
It is important to note that according to this procedure the number of mutated cells 
grows sigmoidally with time. This may indeed be expected as was shown in 
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aforementioned paper (Dobrzyński et al. 2016) in which the sigmoidal dependence on 
dose resulted from overlapping number of linear dependencies. 
It is not easy to calculate how the number of repair enzymes depends on time. 
However, one can assume that the growth should also be described by a sigmoidal 
function, so the postulated eq. (5.3) must be modified. Furthermore, since the number 
of mutations necessary for a neoplastic transformation of a cell is between 2-8 
(Vogelstein et al., 2013, Renan 1993; Hahn et al. 1999; Hahn and Weinberg 2002), 
one can use a formula analogous to eq. (5.4), but with powers 2-8. It may be noted 
that in order to employ their modelling approach to fitting the Cohen’s (1995) data on 
lung cancer vs dose, Fleck et al. (1999) used the power m = 5, which seemed optimal. 
The number of mutations in a cell, m, is critical for a possible neoplastic transformation 
to occur. One can assume that the probability of this transformation is 1 at, say, 10 
mutations, and may depend on the number of mutations in sigmoidal fashion using the 
Avrami-Mehl equation (Dobrzyński et al. 2016) as: 
𝑃𝑐(𝑚) = 1 − 𝑒
−0.0277𝑚𝑘  ,    (5.5) 
which for m = 5 and k = 2 is close to 0.5, and saturates quickly to 1.0 at larger m values. 
Obviously, that form of the sigmoidal curve with its ad hoc assigned parameter value, 
as proposed here in eq. (5.5), does not follow from any first principles (Renan 1993; 
Hahn et al. 1999; Hahn and Weinberg 2002). Generalizing eq. (5.4) to the case of m 
mutations: 
𝑀𝑚 = 𝑀0(1 − 𝑒
−𝐵 𝑃𝑚 𝑡)𝑚 ,   (5.6) 
Using eq. (5.5) one should get some estimation of the number of cells with m mutations 
that transform to cancer cells: 
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𝑁𝑐𝑎𝑛𝑐(𝑚, 𝑡) = 𝑀0(1 − 𝑒
−𝐵𝑃𝑚𝑡)𝑚 (1 − 𝑒−0.0277𝑚
𝑘
) .  (5.7) 
Eq. (5.7) does not take into account any cooperative action within a collection of cells. 
It relates only to the creation of cancer cells from the mutated ones. As an example, 
Fig. 4 shows contour plots in the coordinate system m-t for B·Pm = 0.01 and for the 
exponent k in the eq. (5.7) equal to 2 and 4.  
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Fig. 4 Relative number of cancer cells vs time, t, and the number of mutations per 
cell, m, for various critical exponents k = 2 (upper figure) and 4 (lower figure). 
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The development described by eq. (5.7) must terminate when the number of cancer 
cells, i.e. the sum of Ncanc(m,t) over m: 
𝑁𝑐𝑎𝑛𝑐𝑒𝑟(𝑡) =  ∑ 𝑁𝑐𝑎𝑛𝑐(𝑚, 𝑡)𝑚  ,    (5.8) 
attains some critical value at which the voluminous tumour growth starts. Let us denote 
the time at which such a situation happens by tcr. Fig. 5 shows Ncancer(t) calculated 
under the assumption that the factor B is constant (independent of m) which to our 
understanding may be the case. Fig. 5 shows that the calculated proliferation rate of 
cancer cells with time increases with the increasing critical index of cancer growth. This 
is reasonable as the increase of the critical index means that the rate of transformation 
to a cancer cell must rise. In all cases the curves Ncancer(t) in Fig.5 exhibit a saturation 
and resemble the sigmoidal Gompertz curves. Of note, this saturated value, after 
summing up contributions from all values of m) can be calculated as: 
𝑁𝑐𝑎𝑛𝑐𝑚𝑎𝑥 = lim
𝑡→∞
∑ 𝑁𝑐𝑎𝑛𝑐(𝑚, 𝑡)𝑚 = ∑ 𝑀0 (1 − 𝑒
−0.0277𝑚𝑘 )𝑚         (5.9) 
In a special case when m ≥ 4 and k ≥ 4, one can write that Ncancmax ≈ m·M0. The curves 
in Fig.5 are qualitatively similar to the ones obtained by an analytical approach of 
Dobrzyński et al. (2016), see their Fig.3. The shape of all of the curves is virtually 
identical, differing only by a multiplication factor. These curves are, however, quite 
different from the ones obtained by Fornalski et al. (2011) who used Monte Carlo 
simulations of the cancer cells’ growth. As mentioned earlier, these curves can be 
perfectly described by the Gompertz curve; Fig. 6 shows the fit of the Gompertz curve 
Ncancer(t)=8.27844·exp[-6.51319·exp(-0.010028·t)] to the calculated points for the 
exemplary case of k=4 from Fig. 5. To the best of the authors knowledge, this is the 
first demonstration of the Gompertz curve (which traditionally describes the time of 
growth of cancer cells (Laird 1964)) to be obtained from the combination of the 
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probabilities and the basic biophysical properties considered in this paper. (It is 
particularly noteworthy that the presented calculations, especially Eq. (5.8), do not take 
into account the processes of cell divisions and deaths that could modify the curves 
Ncancer(t).) 
 
 
Fig. 5 Number of cancer cells vs time. The curves in ascending order (from brown to 
blue) correspond to k = 1, 2, 3 and 4, calculated using eq. (5.8) and the assumption 
of B·Pm=0.01. 
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Fig. 6 Calculated number of cancer cells vs time (open circles) from the special case 
of k=4 from Fig. 5, with B·Pm=0.1. The  fitted Gompertz function Ncancer(t) = 
8.27844·exp[-6.51319·exp(-0.010028·t)] (solid line).  
 
As was shown by Dobrzyński et al. (2016), eq. (13), the tumour growth can be also 
described by the Mehl-Avrami type of equation, which is based on the nucleation and 
growth theory. It is important to understand that ‘it takes a tissue to make a tumour’ 
(Barcellos-Hoff 2001), and that ‘the cancer induction is more a function of the tissue 
response and not a single cell response’ (Puukila et al. 2017). Thus, consideration of 
what happens in specific cells rather than in a whole tissue is not sufficient. The tumour 
growth over time is governed by a critical index n showing the spatial type of the 
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growth: linear, 2D or 3D (n=2, 3, and 4, respectively). Finally, the achieved tumour 
volume expressed in terms of the number of cells is characterized by: 
 𝑉 = 𝑁𝑐𝑎𝑛𝑐𝑚𝑎𝑥[1 − 𝑒
−𝛾(𝑡−𝑡𝑐𝑟)
𝑛
] ,   (5.10) 
where Ncancmax denotes the number of cancer cells in this volume, so Ncancmax 
corresponds to the maximum given by eq. (5.9), see Fig. 6. Similar reasoning was used 
by Laird (1964) who originally connected the Gompertz function with tumour growth. 
The coefficient  must be proportional to the dose rate with the same power index, n, 
so the argument of the exponent in eq. (5.10) is directly connected with the dose as 
indicated by Dobrzyński et al. (2016). 
One can wonder when exactly begins the growth of a 3-dimensional cancer. This may 
be just a singular (critical) point as is common in phase transitions or in catastrophes. 
Transition to a self-organized state may also be considered. Whether or not this relates 
in any way to the self-organized criticality theory (Bak 1996) is not yet clear. 
In fact, it can be assumed that in a multistep process of carcinogenesis (Hanahan and 
Weinberg 2000), each step marks a phase transition. Consequently, the ‘cancer 
energy’ landscape of a biological system can be represented by a multitude of energy 
valleys separated by potential barriers. 
The choice of the critical index, n, is not trivial; however, it seems reasonable to limit it 
to 4. Because of the complex nature of a tumour growth this index may not even be an 
integer. Once again, it is crucial to recognize whether one is considering the acute or 
chronic radiation exposure. 
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6. On cancer growth  
Modelling carcinogenesis is an extremely difficult task because of the multitude and 
diversity of cancers as well as their many biological and geometrical features that have 
to be taken into account. As an example, one can consider a hypothetical case of a 
spherical tumour which obtains its nutrients from the surrounding tissues before the 
development of its own vascular system. The nutrients enter the tumour by diffusion 
and their supply decreases with time. A solid tumour itself can contain the inner sphere 
of dead cells and the outer shell of live cancer cells, both quiescent and actively 
proliferating (e.g., Aguda and Friedman, 2008, La Porta and Zapperi, 2017). In a 
slightly more mathematically complicated model than the ones considered heretofore 
by us, after neglecting the shell of the quiescent cells and assuming a constant rate of 
the nutrients’ consumption, one finds (Foryś, 2005) that the volume of the tumour 
changes with time according to equation: 
?̇? =  
𝑘𝑉
𝛾
[1 − (
𝑉
𝜗
)
𝛾
],      (6.1) 
where =2/3, k=2a(cz-ca)/3, a is a scaling constant, 𝜗 =
4𝜋
3
[
15
𝐺
(𝑐𝑧 − 𝑐𝑎)]
3/2
, where cz 
denotes the concentration of nutrients available outside of the tumour, ca is a constant 
that relates to apoptotic cell death, and G denotes the rate of the consumption of 
nutrients. If not for the exponent , the eq. (6.1) would be identical to a logistic equation 
(if  = 1) with limiting value of the volume.  
A more advanced approach to spherical tumours is presented by Jiang et al., 2005. 
Valuable reviews of other analytical models of tumour growth can be found in the 
already cited book by Aguda and Friedman (2008) and a recent monograph by La 
Porta and Zapperi (2017). Most of these models describe in mathematical terms the 
biology of cancer formation. In this respect, equation (6.1) and the ones discussed by 
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us in the previous sections present simplified approaches to this very complicated 
problem. A multiscale model of avascular tumour growth was also considered in detail 
in the book by Aguda and Friedman (2008). By using the real data on the colorectal 
cancer, which has a spheroid shape, these authors showed excellent agreement of 
their experimental results with those of the Monte Carlo calculations presented by 
Jiang et al. (2005) in their Fig.5. The time dependence of the elementary volumes of 
clusters has been assumed to fulfil special requirements related to the capacity of cell 
division. As a result, the growth of the tumour volume turned out to be fairly well 
described, while the growth curve could be fitted with the Gompertz function. On the 
other hand, the solution of eq. (6.1) leads to time dependences with shapes similar to 
the logistic curve as well as to the one showed in our Fig. 6.  
The models presented thus far may be useful in characterizing the time dependence 
of the carcinogenic process. They rely on the following simplistic reasoning: the DNA 
in cells is attacked by ionizing radiation (which is our focus) as well as by free radicals 
(produced during normal aerobic metabolism) which evoke lesions in the DNA 
structure. If unrepaired, these lesions may be passed on to the next generation cells 
and give rise to mutations which, when expressed in proto-oncogenes. and tumour 
suppressor genes may lead to neoplastic transformations of cells. 
As indicated earlier, the existence of radio-adaptive responses induced by low-dose 
irradiations invalidates LNT model employed as a basis for radiation protection 
regulations (Scott, 2017). This is because radiation doses used to demonstrate the 
adaptive response (a small dose followed by a large dose) are not additive as required 
by the LNT model. Moreover, according to this model, potential mutations and 
neoplastic transformations caused by absorption of low radiation doses add to the 
number of spontaneously produced mutations and transformations. However, actual 
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data show that exposures at small radiation doses down-regulate rather than increase 
the amount of such spontaneous effects (Koana et al., 2007; Ogura et al., 2009; Scott 
2014, 2017). 
It is now commonly accepted that cancer indeed arises from a single cell transformed 
through a series of genetic mutations, epigenetic events, and environmental 
determinants that cause and sustain ectopic expression of growth-related genes (see 
the reviews by Kreso and Dick (2014) and Islam et al. (2015)). The cardinal property 
of this single cell is its ‘stemness’, i.e., the capacity for self-renewal and multi-lineage 
differentiation into subclones of daughter cells which, after further genetic and 
epigenetic changes, produce heterogenous populations of cancer cells that shape the 
complex ecosystem of each neoplasm (Allison and Sledge, 2014).  
 
Let’s look at this evolving ecosystem of cancer from another angle. It is clear that by 
passing from single cells to tissues and to organs the organization of the system 
changes significantly. Since one deals with a complex system (Rubin, 2017), 
description of the changes should closely follow the rules of phase transitions (e.g., 
Stanley, 1971) and of self-organization and complexity (e.g., Kauffman, 1993, 
Heylighen, 2008). As pointed out by Heylighen (2008) ‘complex systems consist of 
many (or at least several) parts that are connected via their interactions. Their 
components are both distinct and connected, both autonomous and to some degree 
mutually dependent.’ The other feature of a complex system is that its main units (in 
this case, cancer cells) are free in the sense that they can multiply or die. Obviously, 
this description fully reflects cancer development in the environment of normal cells 
and the extracellular matrix. Notably, however, a rather fundamental question of the 
nature of cancer cells has not been answered so far. According to Soto and 
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Sonnenschein (2005) a cancer represents a problem of tissue organization in which 
emergent phenomena (characteristic for complex systems) are of primary importance. 
Likewise, Mansury et al. (2002) highlight the fact that ‘linear adding-up of individual cell 
behaviour is invalid in the presence of the hypothesized nonlinear interaction among 
tumour cells, and their environment. Moreover, nonlinearity would render it virtually 
impossible to predict the long-run dynamics of the system using a purely analytical 
approach.’ Consequently, one must expect the discontinuities in a description of the 
transitions “from a photon/particle to a cell to a tissue and to a cancer.” In fact, even 
on the level of genes and cells one observes emergent phenomena and the self-
organized criticality (e.g., Tsuchiya et al. 2015). Notably, Mansury et al. (2002) who 
claim that ‘malignant tumours behave as complex dynamic self-organizing and 
adaptive biosystems’ also indicate that distinct phase transition properties can be 
found in the number of cancer cell clusters and their temporal behaviour vs. the intrinsic 
capability of a single cancer cell to migrate. In this context, another important question 
is whether the once formed cancer cell stays as such until its death (Sonnenshein and 
Soto, 2016). Apparently, none of the earlier discussed analytical approaches 
addresses this question. One can also point out the remark by Prehn (1994) that a 
cancer may not be caused solely by mutations in the DNA and a cancer cell may not 
stay as such forever (i.e., can reverse to a normal cell state). Sotto and Sonnenschein 
(2005) suggest therefore that “it may be more correct to say that cancers beget 
mutations than it is to say that mutations beget cancers.”  
In their seminal papers, Hanahan and Weinberg (2000; 2011) indicate that during 
carcinogenesis neoplastically transformed cells acquire critical features called ‘the 
hallmarks of cancer’. These include: growth factors self-sufficiency, insensitivity to anti-
growth signalling, evasion of programmed cell death (apoptosis), limitless replicative 
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potential, sustained angiogenesis, ability to invade and metastasize, genome instability 
and enhanced mutation rate, reprogramming of the energy metabolism, and evasion 
of immune destruction. Additionally, Frederica Cavallo and co-workers (2011) 
proposed two ‘immune hallmarks,’ i.e., the ability of cancer cells to thrive in a 
chronically inflamed environment and to suppress immune reactivity. 
At the beginning of the 21st century Schreiber and his colleagues described a process 
called ‘cancer immunoediting’ whereby the immune system, the most potent guardian 
against neoplasia, prevents cancer development at the early stages of carcinogenesis, 
but also shapes (“edits”) immunogenicity of neoplastic cells and contributes to cancer 
development (Shankaran et al., 2001; Dunn et al., 2002; Shreiber et al., 2011).  
The cancer immunoediting process can be divided into three consecutive phases: 1. 
elimination, during which incipient cancer cells are recognized by the alarmed innate 
immune system which triggers adaptive immune responses that specifically detect and 
destroy neoplasticcells; 2. equilibrium, when humoral and cellularimmune mechanisms 
(e.g., interferon-, interleukin-12, granulocytes, macrophages, T and B lymphocytes) 
hold persisting cancer cells in check (cancer dormancy), but also shape the immune 
status of these cells and their environment; and 3. elimination, during which the extant 
and “immunoedited” (i.e., resistant to immune attack) cancer cells proliferate in the 
immunosuppressive environment facilitating cancer progression toward a full-blown, 
clinically detectable disease (reviewed in Janiak et al. 2017). 
 
From the perspective of this paper the most important is the third phase of cancer 
development. Apparently, during all phases of cancer immunoedition there is a 
competition between stimulation and inhibition of cell proliferation, and between 
dynamic disorder and order. Hence, the use of a deterministic approach, as we did in 
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earlier sections and in eq. (6.1), cannot satisfy the needs: our system is non-linear, and 
should not be described by linear equations as stated explicitly by Mansury et al. 
(2002). Moreover, there is little hope that a reductionists point of view will help us to 
comprehend how a cell is functioning until we fully understand the variety of molecular 
interactions in a normal cell and how cells function within normal tissue, an organ, and 
a cancer. As indicated by Saetzler et al. (2011) ’he upward causation assumption 
completely neglects the contribution of the environment and of the emergent structure 
itself (by downward causation).’ The popular somatic mutation theory (SMT) of cancer 
turns out to be insufficient to explain the variety of cancer behaviour. A tissue 
organization field theory was proposed to better accomodate and explain the emerging 
experimental evidence related to cancer development (Sonnenschein and Soto, 2016).  
With regard to phase transition in a complex system, the natural question is what 
happens close to the point at which phase transition takes place? To what extent can 
such a transition be treated as an emergent phenomenon? Is the loss of control over 
tumour growth a sort of catastrophic event, such as an avalanche (Bak, 1996) treated 
as an indicator of self-organization at the phase-transition, or is it just a phase transition 
of the first or second order, similar to the re-entrant and other transitions of frustrated 
systems from disordered to ordered states (Binder and Kob, 2011). In the case of self-
organization an essential difference between what is going on before and after the 
transition relates to the fact that before the transition every cell more or less individually 
interacts with its closest tissue constituents. In contrast, after the transition, all cells 
work together: what happens in one place of the tumour has a direct influence on what 
happens at any other place. How the situation in one place will change the situation in 
another place of the tumour is hard to predict (possibly abscopal effects may be 
involved). At the beginning, all incipient tumour cells are fed by diffusion from the 
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surrounding tissues and can proliferate. With time, however, the inner core of a tumour 
is formed. Probably, eq. (6.1) may roughly describe the evolution of a tumour volume, 
mainly of its outer shell. From the organization point of view, the larger the tumour, the 
more external, unbounded cancer cells can be accommodated on its surface, and the 
tumour would exponentially grow up to infinity. In any case, within the scope of the 
theory of complexity one has to admit that the process of tumour growth cannot be 
reduced to individual interactions between cells as was possible during the equilibrium 
phase of the immunoediting process. Once the tumour is formed after passing the 
critical point, the tumour cells lose their individuality and become totally subordinated 
to the properties of this new entity. Of course, any stress, such as exposure to ionizing 
radiation, may change this self-organized behaviour. Because of such complexities, 
one has to accept that the description of an organism cannot be reduced to interactions 
between its principal entities and that the organisms are subject to rules of organization 
and its variations, as discussed by Mossio et al. (2016). From a purely physical point 
of view an organism is an open system capable of exchanging energy and matter with 
its environment. These important problems are, however, beyond the scope of the 
present paper. 
Phase transition as discussed here may be also well understood based on the so-
called percolation-type of phase transition. In this case, the main assumption is that a 
single cancer cell is not a cancer itself, and only a group of these cells may constitute 
a tumour. So, at first, individual cancer cells may occasionally form contacts (or links) 
between each other and the functional links may lead to the formation of clusters. 
Within the scope of the continuous time branching processes theory one can calculate 
a cumulative distribution of the cancer colony sizes vs. the number of cells in these 
colonies (see Fig. 3.3 in La Porta and Zappero, 2017). This distribution depends on 
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the time of observation, qualitatively is not very different from the logistic curve, and 
pretty well describes the observations. 
In a further development of such an intertwined network, all the clusters may fill up the 
space in such a way that nutrients provided to one of them can be transferred, to any 
other – the percolation transition is achieved. Likewise, a disturbance occurring in one 
place can be propagated to any other place. In terms of the second order phase 
transitions one should talk about spatial and temporal fluctuations that grow, on 
average, below the transition point and, upon passing this point, freeze to a single 
ordered phase. 
As mentioned in the previous section, a single cancer cell created during the neoplastic 
transformation of a mutated cell is not yet a cancer. Eqs. (5.10) and (6.1) described 
the tumour growth with time. To make a group of cancer cells a tumour, a certain 
number of them, h: 
ℎ =
𝑁𝑐𝑎𝑛𝑐
𝑁𝑐𝑎𝑛𝑐+𝑁𝑛𝑜𝑛_𝑐𝑎𝑛𝑐
 ,     (6.2) 
where Nnon_canc is a sum of damaged and mutated cells (Nnon_canc = Nlesion + Nmut), must 
interact with each other and start to proliferate in a coherent way after passing a certain 
critical value, hc.  
With time, the value of h changes, but as long as cancer cells or their clusters are 
disconnected the tumour has not yet emerged as a separate entity. As already 
indicated, such an emergence can be identified with a phase transition similar to the 
re-entrant phase transitions known from the physics of magnetics or the percolation 
theory. In both cases, the final formation of a given object (e.g., a tumour) appears 
when h exceeds some critical value (e.g., the number of cancer cells, hc), as mentioned 
earlier. Within the scope of the percolation theory, which refrains from purely physical 
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or biological parameters, one needs to define the parameter which should control the 
occupancy of pixels (voxels) into which a given space is subdivided. This parameter 
should reflect not the relative number of cancer cells as in (6.2) but rather the 
probability of the creation of a cancer cell at a given pixel (voxel). Let this probability 
be denoted by p. With time cancer cells aggregate and form clusters that combine with 
each other and finally a critical state is attained: the ‘infinite cluster’ (a tumour) is formed 
in which any information sent from one location in the object can reach all other 
locations with a consequence to the whole object – the tumour starts to behave as an 
entity whose behaviour cannot be derived from individual properties of cells and their 
interactions. This is similar to the sand-pile experiment (Bak,1996): although the grains 
of sand drop to the sand’s cone from the top onto a single point, at a certain height and 
radius of the cone avalanches appear in an unpredictable manner (the so-called self-
organized criticality). In the case of percolation the situation may be visualized by 
imagining a number of pixels or voxels into which one drops small grains or small 
spheres. Next let us connect randomly any two such small spheres. If we repeat this 
procedure, the number of the connected spheres will increase, and the number of 
locally connected spheres (clusters) will increase. At a certain moment the size of those 
clusters will start to suddenly rise. This illustrates a case of self-organization.  
In a typical simulation of a percolation phenomenon (Binder and Kob, 2011) one has 
to choose the size of the object divided into pixels, and by the ‘infinite cluster’ one 
understands the cluster extending from one edge of the object to another one. Ideally, 
the object should have infinite dimensions, so that the meaning of ‘infinite cluster’ is 
literal. In our case the situation is somewhat different. An organ is close to be infinite 
with respect to the size of the cells. The size of tumours in it may not be as large as 
the organ for, e.g., the lack of nutrients needed the cancer to grow (Laird 1967). 
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Nevertheless, one can still treat the maximum size of the tumour as roughly equivalent 
to an infinite lattice of cells and the percolation theory (Stauffer, 1979) with its purely 
geometrical statistical ingredients can be useful for the description of at least a region 
close to the phase transition point, pc. In the case of a site percolation on the square 
lattice pc 0.593. The ‘infinite cluster’ may exist only above pc. Inside the organ, which 
represents a truly infinite lattice, one can imagine formation of more than one ‘infinite 
cluster’, i.e., of more than one tumour. 
According to this theory, the probability that a given cell belongs to the collection of 
tumour cells grows at p > pc in a critical way, and the percolation probability, Pmax, i.e. 
the fraction of the occupied sites belonging to the ‘infinite cluster’ is ruled by the critical 
index which may in general be of the fractal type:  
𝑃𝑚𝑎𝑥~(𝑝 − 𝑝𝑐)
𝛽 .     (6.3) 
This behaviour is displayed in Fig.6. It is neither sigmoidal type nor logistic type, 
however one should remember that the relation (6.3) must describe the behaviour 
mainly in the critical region, i.e. relatively close to pc.  Alas, the width of the critical 
region is difficult to predict. 
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Fig.7 Transition to percolation after passing the pc point assumed to be pc = 0.5 at 
different critical indices  
 
A very illustrative example of this kind of behaviour can be found in many disordered 
magnetic systems, such as a diluted ferromagnet which below pc becomes a 
paramagnet, and becomes ferromagnetic above pc. In addition, over a certain 
concentration range of magnetic species (Co, Fe, …) the spin-glass phase can be 
formed. In such a system the control parameter is temperature – with increasing 
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temperature the value of the percolation probability pc increases as well. As an 
example, the onset of ferromagnetism in a percolating 3D network of the random fcc 
(face centered cubic) alloys can be satisfactorily described within the framework of the 
percolation theory, where pc ranges from 0.16 to 0.20 (Childress and Chien, 1991). 
Often the phase diagram of such diluted ferromagnets can be described within the 
framework of the so-called Ising model. In the case of cancer one encounters a more 
complex situation because the number of states representing cells with different 
degrees of lesions and mutations is much higher than the number of up and down 
spins in Ising model. This makes statistical description of the state below pc more 
difficult.  
 
 
 
47 
 
 
Fig.8 Schematic phase diagram of a diluted ferromagnet (e.g. Au-Fe, Co-Cu etc.) 
showing phase transitions between paramagnetic (PM), ferromagnetic (FM) and spin-
glass (SG) phases depending on temperature and concentration X of the magnetic 
sample. 
 
 
It should be mentioned that the sharp transition shown in Fig.7 may be smeared if one 
finds correlations between the cells below pc. If such correlation exists between the 
states of a two cells separated from each other by a distance R,  one can find a function 
describing such a correlation. In a typical magnetic system it would be described by a 
function decreasing exponentially with the distance. This would lead to a substantial 
48 
 
change in Fig. 7: the whole curve becoming sigmoidal-like, such as the one in Fig. 3.9 
of Binder and Kob, 2011.  
Just below the transition point the average distance between the cells within a cluster 
(correlation length), , behaves as: 
~(𝑝𝑐 − 𝑝)
− ,    (6.4) 
where  denotes another critical exponent. The values of both exponents depend on 
grid and slightly differ depending on case2.  For example, for a 3-dimensional net  = 
0.418  0.001, and ν = 0.875  0.008. The mean cluster size also exhibits non-
analytical behaviour:  
𝑆~ (𝑝𝑐 − 𝑝)
−𝛾 ,    (6.5) 
with = 1.793  0.003. In the case of two-dimensional growth the critical exponents 
change to 5/36, 4/3 and 43/18 for , andrespectively. Let us note that the critical 
exponents depend on the dimensionality of the problem and not on the microscopic 
properties of the system. The whole situation resembles the behaviour of magnetic 
systems: our p plays a role similar to temperature, percolation probability Pmax – 
magnetization,   - correlation length, and S – magnetic susceptibility. Below the 
transition point one can also make intuitive use of the so-called mean-field approach. 
Namely, let the number of cancer cells be Ncanc, whereas Ncanc,0 is the number of cancer 
cells whose  growth seem to be inhibited by immunological forces and represent 
dormant cells. The development of cancer cells may depend on their number that form 
a special field due to interaction of these cells with their environment (in fact, it is the 
question of competing forces between natural expansion of cancer cells and the 
                                                             
2 https://en.wikipedia.org/wiki/Percolation_critical_exponents#Exponents_for_standard_percolation 
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immune restrain of such a development, see Janiak et al, 2017). This field describes 
something analogous to a promotion of the development of cancer with a multiplication 
factor, say, . Then one can write a simple equation: 
𝑁𝑐𝑎𝑛𝑐 = 𝑁𝑐𝑎𝑛𝑐,0 +  𝑁𝑐𝑎𝑛𝑐 .   (6.6) 
Thus; 
𝑁𝑐𝑎𝑛𝑐 =  
𝑁𝑐𝑎𝑛𝑐,0
1−
 ,     (6.7) 
which shows how the number of cancer cells can be strongly enhanced by the 
interaction of these cancer cells with their environment. In an extreme case the number 
of cancer cells can reach the total number of cells if  = 1, i.e., when immunological 
protection against cancer development breaks down. Eg. (6.7) is a typical result 
obtained within the framework of the mean-field theory of phase transitions. The 
problem to be solved is the description of the form of . It is not a single number but a 
function depending on the processes of immunological protection against cancer. In 
fact, all the aforementioned steps in cell behaviour represent some phase transitions 
although an appropriate mathematical description of these transition is rather difficult. 
Consequently, one needs to define the so-called order parameter which changes upon 
transition. This parameter must have defined dimensionality, while one should also 
define whether the main interaction mechanism with environment is short- or long-
ranged. Besides, it seems that one deals with three space-time scales: the one of 
signal transduction, the short-range adaptive response and bystander effect,  and the 
long-ranged abscopal effect. 
Presently, the above described critical phenomena are difficult to observe at present 
as the minimum size of the detectable tumour is of the order of a few milimeters, when 
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the tumour is already formed. In spite of this obstacle, one should understand that the 
general properties of phase transitions, including self-organization and/or self-
organized criticality have to be included in a rigorous description of the tumour 
development.  
 
7. Conclusions 
There are several problems covered in this paper. Its intention was to separate the 
evolution of individual cells from that taking place in a tissue. With this aim in mind, the 
approach of Fleck et al. (1999) was initially examined. Although the ideas behind their 
model are quite different from the ones presented previously by us (Dobrzyński et al. 
2016), the final result for the number of cancer cells vs time has turned out to be 
qualitatively similar. Notably, in contrast to Fleck et al. (1999) who used dose rate, 
Dobrzyński et al. (2016) employed dose in their calculations. Moreover, a more 
fundamental difference in the way a cell repairs its DNA lesions is presented in the 
presented paper. In the model of Fleck et al. (1999) the dependence of the time of 
repair of a single DNA lesion on the dose rate plays an essential role. Apart from the 
fact that a postulated modification of the repair time with increasing dose rate may be 
described by a different function, the model of Fleck et al. (1999) explains Cohen’s 
(1995) data on lung cancer mortality vs radon-specific activity. However, it seems that 
one cannot go too far with a function fitted to data, as the mortality calculated in this 
way soon exceeds the hormetic minimum. Such an increase is not confirmed by the 
numerous other data collected for much higher radon concentrations (Dobrzyński et 
al. (2018), (Henriksen, 2015). 
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Our attention has also been paid to the dependence of adaptive response on the time 
and the dose, associated with acute or protracted radiation exposures. We 
demonstrate that in the case of a protracted exposure, the organism attains a certain 
saturation in its ability to repair lesions (Fig. 5). This observation permits us to treat 
absorbed dose as a priming dose which allows to better tolerate higher and more 
challenging doses.  
Increase in the number of cancer cells in an organism depends on the timing and the 
dynamics of the critical number of mutations in a cell needed for its transformation into 
a cancer cell. As demonstrated by us, this may be described by a pretty complicated 
function (5.7). However, the increase in the total number of tumour cells (Fig.5) when 
graphed, resembles a sigmoidal shape of the Gompertz function. As previously 
indicated by Dobrzyński et al. (2016), the 3-dimensional growth of the tumour volume 
may generally be described by a sigmoidal curve given by the nucleation and growth 
according to the Avrami-Mehl theory as discussed in Dobrzyński et al. (2016).  
Finally, we have discussed at length the problem of tumour growth. Description of this 
process is inherently difficult. Firstly, it essentially deals with the phase transition 
phenomenon, and the type of this transition is not clear. Essentially, there is a transition 
from a disordered phase (represented by individual cancer cells and their clusters) to 
an ordered one (the developed tumour) which exhibits properties not directly 
connected to individual processes occurring in its basic units (cells). If this is the case, 
one is dealing with an emergent phenomenon, the self-organization and the possible 
self-organized criticality. However, even if the phase transition can be viewed as a 
continuous one (of second order) it is difficult to specify its most important parameters: 
the order parameter and its dimension, as well as the interaction range between cells, 
and the control parameter (usually temperature in a magnetic system or in, e.g., liquid-
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gas transition). Depending on these parameters one could specify the values of critical 
exponents characterizing the transition. An important property of such critical indices 
is their universality – they are not directly related to microscopic interactions between 
the basic units of the system. However, when a mathematical description is given, its 
experimental verification can be difficult. Today, a tumour cannot be detected if its 
diameter is around 2-3 mm. This means that it is already far beyond the phase 
transition region where critical properties can be observed. To illustrate the problem, 
phase transitions of the percolation type were considered. Additionally, a simple 
application of the mean field theory shows that non-analytical behaviour is to be 
expected if a phase transition takes place. We plan to address these problems in a 
future publication. 
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Appendix A 
In the case of a single photon of gamma or X-ray radiation, one must consider cross 
sections for the photoelectric effect (σph), for Compton scattering (σC), for electron-
positron pair production in the nuclear field (σpair), and for similar pair production in the 
electron field, so-called triplet production (σtriplet). Thus the total cross section for the 
interaction of gamma- and/or X-rays with matter can be described by: 
𝜎(𝑅, 𝐸) = 𝜎𝑝ℎ + 𝑍𝜎𝐶 + 𝜎𝑝𝑎𝑖𝑟 + 𝑍𝜎𝑡𝑟𝑖𝑝𝑙𝑒𝑡 ,    (A0) 
where Z is the atomic number of the absorbing material (note that Compton and triplet 
effects cross sections are calculated for single electrons). In fact, Eq. (A0) describes 
the ionization processes that can happen in a cell. The equation written in extended 
form is rather complicated and will not be presented here – all necessary terms on the 
r.h.s. of Eq. (A0) can be found in the literature (Hubbell et al. 1980).  
 
Appendix B 
The basis for the quasi-linear dependence of Phit  (Fornalski et al. 2011): 
𝑃ℎ𝑖𝑡 = 1 − exp (−𝑐𝐷)     (B0) 
stems from a simple observation: let us imagine that single cell is composed of N pixels 
which can be hit by radiation. Some number of them, say n, are important from 
radiobiological point of view and represent e.g. cellular DNAs. Thus, the probability of 
DNA damage made in a pixel by a single particle hit is n/N. In case of two particles 
impinging on the considered cell this probability changes to: 
𝑃2 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 = 2 (
𝑛
𝑁
∙
𝑁−𝑛
𝑁
) + (
𝑛
𝑁
)
2
   (B1) 
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because one shall consider three scenarios: i) first particle hit DNA and the second 
not, ii) analogical to the previous one, but the opposite, iii) two particle hit DNA. For 
many (k) particles, where some of them hit DNA, one can use the sum of binomial 
distribution functions as: 
𝑃𝑘 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 = ∑
𝑘!
𝑟! (𝑘−𝑟)!
𝑘
𝑟=1 (
𝑛
𝑁
)
𝑟
(1 −
𝑛
𝑁
)
𝑘−𝑟
  (B2) 
If not the lack of the term with r = 0 (none of particles hit DNA), eq. (B2) would be 
nothing else than binomial of [n/N + (1-n/N)]k which is obviously equal to 1. The missing 
term is 
𝑃0 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 = (
𝑘
0
) (
𝑛
𝑁
)
0
(1 −
𝑛
𝑁
)
𝑘
= (1 −
𝑛
𝑁
)
𝑘
   (B3) 
which should be added to the probability Pk particles for r ϵ [1,k], as in eq. (A2). Thus 
1 = 𝑃𝑘 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 + (1 −
𝑛
𝑁
)
𝑘
    (B4) 
and 
𝑃𝑘 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 = 1 − (1 −
𝑛
𝑁
)
𝑘
    (B5) 
In the case of n<<N (which is always correct in our case) the second term on r.h.s of 
(B5) presents first order expansion of exp(-kn/N) (Maclaurin series equation) and finally 
one finds that 
𝑃𝑘 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 = 1 − 𝑒
−
𝑛
𝑁
𝑘 ≡ 𝑃ℎ𝑖𝑡    (B6) 
which is the same as Phit from the eqs (2.2) and (B0), where c=n/N represents the 
probability of DNA hit and k (number of particles) corresponds to the dose (dose per 
numerical step). 
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The presented approach is analogous to the Target Theory (Lea 1955) applied 
originally to the survival of a group of irradiated cells. 
 
Appendix C 
For to ≤ t ≤ t1 the time-dependent integral term can be written as 
𝐼(𝑡) =  ∫ (𝑡 − ℎ)𝑚𝑒−𝛼3(𝑡−ℎ)𝑑ℎ
𝑡
𝑡0
 ,   (C1) 
and for t ≥ t1: 
𝐼(𝑡) =  ∫ (𝑡 − 𝑡0 − ℎ)
𝑚𝑒−𝛼3(𝑡−𝑡0−ℎ)𝑑ℎ
𝑡−𝑡0
𝑡−𝑡1
 ,  (C2) 
which for m=1 or m=2 is easy to calculate: 
for m = 1:  
𝐼(𝑡0 ≤ 𝑡 ≤ 𝑡1) =
1
𝛼3
2 −  (
1
𝛼3
2 +  
𝑡−𝑡0
𝛼3
) 𝑒−𝛼3(𝑡−𝑡0) ,  (C3) 
𝐼(𝑡 ≥ 𝑡1) =  [(
1
𝛼3
2 +  
𝑡−𝑡1
𝛼3
) 𝑒−𝛼3(𝑡−𝑡1)] − [(
1
𝛼3
2 +  
𝑡−𝑡0
𝛼3
) 𝑒−𝛼3(𝑡−𝑡0)] , (C4) 
and for m = 2: 
𝐼(𝑡0 ≤ 𝑡 ≤ 𝑡1) =
2
𝛼3
3 − [
(𝑡−𝑡1)
2
𝛼3
+
2(𝑡−𝑡1)
𝛼3
2 +
2
𝛼3
3] 𝑒
−𝛼3(𝑡−𝑡1) ,  (C5) 
𝐼(𝑡 ≥ 𝑡1) =  [
(𝑡−𝑡1)
2
𝛼3
+
2(𝑡−𝑡1)
𝛼3
2 +
2
𝛼3
3] 𝑒
−𝛼3(𝑡−𝑡1) −  [
(𝑡−𝑡0)
2
𝛼3
+
2(𝑡−𝑡0)
𝛼3
2 +
2
𝛼3
3] 𝑒
−𝛼3(𝑡−𝑡0). (C6) 
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